Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637HAF6NOTE 1.000% 8/1HALOQ1 2026
No Form 4 insider transactions ingested yet
Insider (Form 4) filings for Halozyme Therapeutics Inc are fetched from SEC EDGAR on a rolling basis. Check back shortly.